OSAM
ACET icon

O'Shaughnessy Asset Management’s Adicet Bio ACET Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed – – 1262
2021
Q3 		$0 Hold
3
– – ﹤0.01% 2698
2021
Q2 		$1K Hold
3
– – ﹤0.01% 2362
2021
Q1 		$1K Hold
3
– – ﹤0.01% 2124
2020
Q4 		$1K Hold
3
– – ﹤0.01% 1880
2020
Q3 		$1K Hold
3
– – ﹤0.01% 1687
2020
Q2 		$1K Buy
+3
New +$589 ﹤0.01% 1550

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

O'Shaughnessy Asset Management's ACET Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Adicet Bio (ACET) in Q4 2021, closing a stake of 3 shares.

O'Shaughnessy Asset Management first reported a position in ACET in Q2 2020 and held it in 6 quarters. The position peaked at $1K in Q2 2021. 81 funds tracked by Wall St. Rank hold ACET as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Adicet Bio position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 3 Adicet Bio shares in Q4 2021.
  • O'Shaughnessy Asset Management first reported a position in Adicet Bio in Q2 2020 and held it in 6 quarters.
  • O'Shaughnessy Asset Management's Adicet Bio position peaked at $1K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.